Water-Soluble Small Organic Fluorophores for Oncological Theragnostic Applications: Progress and Development

Ashanul Haque1,2, Khalaf M Alenezi3,4, Abdulmohsen Khalaf Dhahi Alsukaibi3,4

  • 1Department of Chemistry, College of Science, University of Ha'il, 81451, Ha'il, Saudi Arabia. a.haque@uoh.edu.sa.

Insights

This review highlights water-soluble fluorescent probes for improved cancer diagnosis and therapy. These advanced probes offer high sensitivity and water solubility for noninvasive imaging and effective theranostics.

Area of Science:

  • Biomedical Engineering
  • Organic Chemistry
  • Oncology

Background:

  • Cancer remains a leading cause of death globally, often due to late detection and metastasis.
  • Noninvasive luminescence-based imaging offers a promising, sensitive, and cost-effective approach for early cancer detection.
  • Developing fluorescent probes with high water solubility and tumor-specific uptake is crucial for advanced cancer diagnostics and therapeutics.

Purpose of the Study:

  • To review recent advancements in water-soluble small organic fluorophores for cancer applications.
  • To systematically discuss fluorophore structures, water solubility strategies, and theranostic applications.
  • To highlight emerging molecular engineering methods and future challenges in the field.

Main Methods:

  • Literature review of water-soluble small organic fluorophores.
  • Analysis of fluorophore structures (coumarin, xanthene, BODIPY, cyanine, etc.).
  • Discussion of strategies for enhancing water solubility and molecular engineering.

Main Results:

  • Several classes of water-soluble fluorophores emitting in visible and near-infrared regions have been reported.
  • These probes demonstrate potential for enhanced cancer diagnosis and therapy (theranostics).
  • Emerging molecular engineering techniques are improving probe design and performance.

Conclusions:

  • Water-soluble fluorescent probes are vital for sensitive, noninvasive cancer detection and treatment.
  • Continued research in molecular engineering will drive the development of next-generation theranostic agents.
  • Addressing challenges in probe design and application is key to clinical translation.